These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 23399651)
81. Tissue immunoexpression of IL-6 and IL-18 in aging men with BPH and MetS and their relationship with lipid parameters and gut microbiota-derived short chain fatty acids. Ratajczak W; Laszczyńska M; Rył A; Dołęgowska B; Sipak O; Stachowska E; Słojewski M; Lubkowska A Aging (Albany NY); 2023 Oct; 15(20):10875-10896. PubMed ID: 37847180 [TBL] [Abstract][Full Text] [Related]
82. Influence of metabolic syndrome on the relationship between fatty acids and the selected parameters in men with benign prostatic hyperplasia. Grzesiak K; Rył A; Ratajczak W; Stachowska E; Rotter I; Słojewski M; Sipak O; Walczakiewicz K; Laszczyńska M Aging (Albany NY); 2019 Mar; 11(5):1524-1536. PubMed ID: 30867336 [TBL] [Abstract][Full Text] [Related]
83. Vitamin D Deficiency at Diagnosis Increases All-Cause and Prostate Cancer-specific Mortality in Jamaican Men. McGrowder D; Tulloch-Reid MK; Coard KCM; McCaw-Binns AM; Ferguson TS; Aiken W; Harrison L; Anderson SG; Jackson MD Cancer Control; 2022; 29():10732748221131225. PubMed ID: 36180132 [TBL] [Abstract][Full Text] [Related]
84. Plasma sex hormone-binding globulin binding capacity in benign prostatic hypertrophy and prostatic carcinoma: comparison with an age dependent rise in normal human males. Dennis M; Horst HJ; Krieg M; Voigt KD Acta Endocrinol (Copenh); 1977 Jan; 84(1):207-14. PubMed ID: 64100 [No Abstract] [Full Text] [Related]
85. Intrinsic and extrinsic factors causing hyperplasia of the prostate. Kyoda Y; Shibamori K; Shindo T; Maehana T; Hashimoto K; Kobayashi K; Tanaka T; Fukuta F; Masumori N Int J Urol; 2024 Jul; 31(7):705-717. PubMed ID: 38462732 [TBL] [Abstract][Full Text] [Related]
86. The association between body mass index and testosterone deficiency in aging Chinese men with benign prostatic hyperplasia: results from a cross-sectional study. Wu Y; Xu D; Shen HB; Qian SB; Qi J; Sheng XJ Aging Male; 2020 Dec; 23(5):841-846. PubMed ID: 31058560 [TBL] [Abstract][Full Text] [Related]
87. Sex hormone therapy in the treatment of carcinoma of the prostate and benign prostatic hypertrophy. HECKEL NJ Clinics; 1946 Dec; 5(4):860-77. PubMed ID: 20283908 [No Abstract] [Full Text] [Related]
88. Vitamin K: the missing link to prostate health. Donaldson MS Med Hypotheses; 2015 Mar; 84(3):219-22. PubMed ID: 25613567 [TBL] [Abstract][Full Text] [Related]
89. Estrogen in the etiopathogenesis of BPH. Farnsworth WE Prostate; 1999 Dec; 41(4):263-74. PubMed ID: 10544300 [TBL] [Abstract][Full Text] [Related]
90. The association between several serum micronutrients and benign prostatic hyperplasia: Results from NHANES 2003-2006. Zhou H; Xu M; Pan Y; Wang S; Xu Z; Liu L; Liu X Prostate; 2024 Feb; 84(2):212-220. PubMed ID: 37899678 [TBL] [Abstract][Full Text] [Related]
91. Immunohistochemical detection of a sex hormone binding globulin like antigen in tissue sections of normal human prostate, benign prostatic hypertrophy and normal human endometrium. Sinnecker G; Hiort O; Mitze M; Donn F; Neumann S Steroids; 1988 Oct; 52(4):335-6. PubMed ID: 2471297 [No Abstract] [Full Text] [Related]
92. Lifestyle habits to prevent the development of benign prostatic hyperplasia: Analysis of Japanese nationwide datasets. Nagakura Y; Hayashi M; Kajioka S Prostate Int; 2022 Dec; 10(4):200-206. PubMed ID: 36570647 [TBL] [Abstract][Full Text] [Related]
93. Benign prostatic hyperplasia and uterine leiomyomas in a female pseudohermaphrodite: a case report. Heyns CF; Rimington PD; Kurger TF; Falck VG J Urol; 1987 Jun; 137(6):1245-7. PubMed ID: 2438432 [TBL] [Abstract][Full Text] [Related]
94. Re: Hypovitaminosis D is Associated with Lower Urinary Tract Symptoms and Benign Prostate Hyperplasia in Type 2 Diabetes. Kaplan SA J Urol; 2017 Aug; 198(2):224-225. PubMed ID: 29370592 [No Abstract] [Full Text] [Related]
95. Endocytosis of sex steroids: the hypothesis of free hormones revisited. Willnow TE; Hammes A; Nykjaer A Ann Endocrinol (Paris); 2008 Apr; 69(2):101-2. PubMed ID: 18407242 [No Abstract] [Full Text] [Related]
96. [Clinical studies on serum lipids in the patients with tumor of the prostate gland. 1st Report: Serum lipids and lipoprotein fraction levels in the patients with benign prostatic hypertrophy and prostatic cancer (author's transl)]. Yoshida H; Shimada M; Imamura K Nihon Hinyokika Gakkai Zasshi; 1980 Jan; 71(1):51-8. PubMed ID: 6155500 [No Abstract] [Full Text] [Related]
97. Benign prostatic hyperplasia, metabolic syndrome and androgenic alopecia: Is there a possible relationship? Agamia NF; Abou Youssif T; El-Hadidy A; El-Abd A Arab J Urol; 2016 Jun; 14(2):157-62. PubMed ID: 27489744 [TBL] [Abstract][Full Text] [Related]
98. Analysis of platelet and monocyte-to-lymphocyte ratio and diabetes mellitus with benign prostatic enlargement. Chen G; Feng L Front Immunol; 2023; 14():1166265. PubMed ID: 37492582 [TBL] [Abstract][Full Text] [Related]
99. Association between benign prostate hyperplasia and metabolic syndrome in men under 60 years old: a meta-analysis. Wu S; He H; Wang Y; Xu R; Zhu B; Zhao X J Int Med Res; 2019 Nov; 47(11):5389-5399. PubMed ID: 31612766 [TBL] [Abstract][Full Text] [Related]
100. Benign prostatic hyperplasia: dietary and metabolic risk factors. Nandeesha H Int Urol Nephrol; 2008; 40(3):649-56. PubMed ID: 18246440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]